Analysis of the literature identified a number of studies implicating mutated BRCA1/2 genes were responsible for a significant fraction of prostate, pancreatic and stomach cancer development, as well as susceptibility to advanced disease. This evidence concerns the gene BRCA1 and gastric cancer.